Cover von Antisense therapeutics opens in new tab

Antisense therapeutics

0 ratings
Search for this author
Year: 2005
Publisher: Totowa, NJ, Humana Press
Series: Methods in molecular medicine; 106
Media group: Ausleihbestand
available

Copies

BranchLocationsStatusReservationsDue dateBarcodeFloor planLending note
Branch: Hauptstelle Locations: ME-30 78 Status: available Reservations: 0 Due date: Barcode: 00178713 Floor plans: Floor plan Lending note:

Content

1. Antisense Therapeutics: A Promise Waiting to Be Fulfilled
M. Phillips
pp. 3-10
 
 
2. Antisense Inhibition: Oligonucleotides, Ribozymes, and siRNAs
Y. Clare Zhang; Meghan Taylor; Willis Samson; M. Phillips
pp. 11-34
 
 
3. Local Application of Antisense for Prevention of Restenosis
Patrick Iversen; Nicholas Kipshidze; Jeffrey Moses; Martin Leon
pp. 37-50
 
 
4. Antisense Therapeutics for Hypertension: Targeting the ReninAngiotensin System
M. Phillips; Birgitta Kimura
pp. 51-68
 
 
5. Antisense Strategies for Treatment of Heart Failure
Sian Harding; Federica del Monte; Roger Hajjar
pp. 69-82
 
 
6. Clinical Studies of Antisense Oligonucleotides for Cancer Therapy
Rosanne Orr; F. Dorr
pp. 85-112
 
 
7. Antisense Therapy in Clinical Oncology: Preclinical and Clinical Experiences
Ingo Tamm
pp. 113-134
 
 
8. RadionuclidePeptide Nucleic Acid in Diagnosis and Treatment of Pancreatic Cancer
Eric Wickstrom; Xiaobing Tian; Nariman Amirkhanov; Atis Chakrabarti; Mohan Aruva; Ponugoti Rao; Wenyi Qin; Weizhu Zhu; Edward Sauter; Mathew Thakur
pp. 135-192
 
 
9. Suppression of Pancreatic and Colon Cancer Cells by Antisense K-ras RNA Expression Vectors
Kazunori Aoki; Shumpei Ohnami; Teruhiko Yoshida
pp. 193-204
 
 
10. Induction of Tumor Cell Apoptosis and Chemosensitization by Antisense Strategies
Manuel Rieber; Mary Strasberg-Rieber
pp. 205-214
 
11. Utility of Antioncogene Ribozymes and Antisense Oligonucleotides in Reversing Drug Resistance
Tadao Funato
pp. 215-234
 
 
12. Transport of Antisense Across the BloodBrain Barrier
Laura Jaeger; William Banks
pp. 237-252
 
 
13. Transdermal Delivery of Antisense Oligonucleotides
Rhonda Brand; Patrick Iversen
pp. 255-270
 
 
14. Antisense Strategies for Redirection of Drug Metabolism: Using Paclitaxel as a Model
Vikram Arora
pp. 273-292
 
 
15. Antisense Oligonucleotide Treatment of Inflammatory Bowel Diseases
Bruce Yacyshyn
pp. 295-306
 
 
16. Optimizing Electroporation Conditions for Intracellular Delivery of Morpholino Antisense Oligonucleotides Directed Against the Hepatitis C Virus Internal Ribosome Entry Site
Ronald Jubin
pp. 309-322

Ratings

0 ratings
0 ratings
0 ratings
0 ratings
0 ratings

Details

Search for this author
Statement of Responsibility: edited by M. Ian Phillips
Year: 2005
Publisher: Totowa, NJ, Humana Press
opens in new tab
Classification: Search for this systematic ME-30, ME-10, ME-20
Subject type: Search for this subject type Methodenbuch
ISBN: 1588292053
ISBN (2nd): 9781588292056
Description: 2. edition, XII, 327 S. : Ill., graph. Darst.
Series: Methods in molecular medicine; 106
Tags: Antisense nucleic acids; Therapeutic use; LC; Oligonucleotides, Antisense; NLM; Pharmacology; Medizin; Pharmazie; Medizin allgemein; Pharmakologie
Participating parties: Search for this character Phillips, M. Ian [Hrsg.]
Language: englisch||
Footnote: Literaturangaben
Media group: Ausleihbestand